A chemist displays hydroxychloroquine tablets in New Delhi, India. - AP file pic
NEW DELHI: India has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of Covid-19 patients as it partially lifts its bar on exports of the anti-malarial drug.
India is the world’s largest producer of hydroxychloroquine, sales of which have soared across the world including in the United States, especially after President Donald Trump touted it as a potential weapon against Covid-19, the disease caused by the novel coronavirus.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
